Soleimanian Yasamin, Goli Sayed Amir Hossein, Varshosaz Jaleh, Di Cesare Mannelli Lorenzo, Ghelardini Carla, Cirri Marzia, Maestrelli Francesca
Department of Food Science and Technology, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran.
Department of Chemistry, University of Florence, via Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Pharmaceutics. 2020 Apr 22;12(4):386. doi: 10.3390/pharmaceutics12040386.
The objective of the present study was to explore the potential of nanostructured lipid carriers (NLCs) for improving the oral delivery of β-sitosterol, a poorly water-soluble bioactive component with hypocholesterolemic activity. Two β-sitosterol formulations with different solid lipid compositions were prepared by melt emulsification, followed by the sonication technique, and the effect of storage conditions and simulated digestion on the physical, chemical and oxidative stability, bioaccessibility and release were extensively studied. Both NLC preparations remained relatively stable during the four weeks of storage at different conditions (4, 25 and 40 °C), with more superior stability at lower temperatures. The in vitro digestion experiment indicated a high physical stability after exposure to the simulated mouth and stomach stages and an improved overall β-sitosterol bioaccessibility at the end of the digestion. The NLCs presented an increased solubility and gradual release which could be justified by the remarkable affinity of β-sitosterol to the complex lipid mixture. An in vivo study demonstrated an improved reduction in the total cholesterol and low-density lipoprotein cholesterol plasma levels in mice compared with the drug suspension. These investigations evidenced the potential of the developed NLC formulations for the enhancement of solubility and in vivo performance of β-sitosterol.
本研究的目的是探索纳米结构脂质载体(NLCs)在改善β-谷甾醇口服给药方面的潜力,β-谷甾醇是一种具有降胆固醇活性的水溶性较差的生物活性成分。通过熔融乳化法,随后采用超声技术制备了两种具有不同固体脂质组成的β-谷甾醇制剂,并广泛研究了储存条件和模拟消化对其物理、化学和氧化稳定性、生物可及性及释放的影响。两种NLC制剂在不同条件(4、25和40°C)下储存四周期间均保持相对稳定,在较低温度下稳定性更佳。体外消化实验表明,在模拟口腔和胃阶段后具有较高的物理稳定性,并且在消化结束时整体β-谷甾醇生物可及性有所提高。NLCs表现出溶解度增加和逐渐释放的特性,这可以通过β-谷甾醇对复合脂质混合物的显著亲和力来解释。一项体内研究表明,与药物混悬液相比,小鼠血浆中总胆固醇和低密度脂蛋白胆固醇水平的降低更为显著。这些研究证明了所开发的NLC制剂在提高β-谷甾醇溶解度和体内性能方面的潜力。